ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382050 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382050; 2) Community: the network communities that were significantly associated with the response to NSC 382050; 3) Molecule: the relationships between components within communities and NSC 382050; 4) MDR: the compounds that were significantly associated with the NSC 382050.

NSC Compound Enrichment Correlation
NSC 762908 2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one 0.0480633950058475 0.38780832
NSC 81280 Null 0.0480633950058475 0.00089554472
NSC 685794 Null 1.2187791866317e-005 0.14941138
NSC 382034 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- 1.28471457484892e-008 0.72311763
NSC 372939 Null 1.51334527327942e-005 0.6551139
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 3.31921050119509e-005 0.37273209
NSC 692574 Null 3.52090010908441e-005 0.48653337
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 3.52090010908444e-005 0.586529
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 3.52090010908444e-005 0.60785804
NSC 382046 Null 4.35666174401505e-006 0.60677269
Total:98  Current:97    [First] [Prev] [Next] [Last]